RAP-219 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

RAPP stock gains on RAP-219 clinical success as Wall Street weighs modest treatment benefit

Pharming Group tightens 2026 revenue guidance to $380m–$390m after strong third-quarter sales

Macron tightens France protest restrictions as nationwide unrest raises fears of another violent weekend

US Justice Department plans 1,000 election monitors as states challenge federal oversight

Read More

Pharma Industry News

RAPP stock gains on RAP-219 clinical success as Wall Street weighs modest treatment benefit

Rapport Therapeutics' RAP-219 trial lifts RAPP stock as investors weigh its bipolar mania potential. Discover the Phase 3 outlook and market risks.

bySoujanya Ravi

October 22, 2026

web analytics